Harlequin ichthyosis affects just a handful of newborns each year in the US, but the condition is unmistakable, marked by a thick, armor-like layer of hard scales at birth. Once considered a death ...

"I had been pretty healthy," Nicole said. "So, to find out that I got this, I thought, well I'm so healthy, I don't know, ...

The IL-36 inhibitor is being explored for additional inflammatory skin conditions, aiming to expand treatment options for underserved patient groups.

Dermatologists are the first to identify the different types of skin diseases, but when a rare condition comes up, it can be passed to the University’s Stem Cell Institute for treatment. On Nov. 1, ...

The long list of therapeutic uses for Sanofi and Regeneron's Dupixent has been lengthened by an FDA approval for rare skin disease bullous pemphigoid.

Sanofi and Regeneron Pharmaceuticals said they got Food and Drug Administration approval for anti-inflammatory drug Dupixent as a treatment for a rare skin disease, adding an eighth indication in ...

German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening skin disorder generalised pustular psoriasis (GPP), in ...

“Matter of Time,” a documentary featuring legendary rocker Eddie Vedder premiering this fall at the Tribeca Film Festival, is being billed as much more than a concert film – it’s a ...

Barely a year after the U.S. FDA shackled Abeona Therapeutics Inc.’s cell-based gene therapy with a complete response letter, the agency has approved it for treating a rare and genetic skin disease.

Ryan Becker has been fighting a rare skin disease since January, leaving him unable to work at his Spokane County job.

PinCell is a biotechnology company targeting a novel pathological pathway to develop first-in-class anti-inflammatory therapies for the treatment of rare, severe and highly undertreated skin diseases.

A Utah woman is sharing her story after she survived an incredibly rare and often fatal skin disorder caused by an allergic ...